a company working on personalising immunotherapy with data and algorithms
Ellogon has raised €1.0M across 1 funding round from 2 investors, most recently a round in Mar 2024. Based in Amsterdam, Netherlands; active in Healthtech. Data as of 6 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-03-12 | Other | €1.0M |
| ROM InWest,UvA Ventures Holding |
| View deal → |
